Phenytoin-folate interactions: How far is safe folate supplementation in phenytoin treated epileptic patients?

Journal of Applied Pharmaceutical Science

Volumn 2, Issue 6, 2012, Pages 230-235

  Nayyar, Abhishek Singh ^a   Nataraju, B ^a   Subhas, G T ^a  

^a GOVERNMENT DENTAL COLLEGE AND RESEARCH INSTITUTE   (India)

Author keywords

Anti convulsant; Folate metabolism; Phenytoin; Seizures

Indexed keywords

EID: 84876033127     PISSN: None     EISSN: 22313354     Source Type: Journal    
DOI: 10.7324/JAPS.2012.2641     Document Type: Article

References (58)

1. Abramsky l, Noble J. Effects of folic acid [letter]. Lancet 2002;359:2039.
2. Bailey LB, Berry RJ. Folic acid supplementation and the occurrence of congenital heart defects, oro-facial clefts, multiple births and miscarriage. Am J Clin Nutr 2005;81:1213-7.
3. Baxter MG, Miller AA, Webster RA. Some studies on the convulsant action of folic acid. Br J Pharmacol 1973;48:350-1.
4. Berg MJ, Rivey MP, Schottelius DD. Phenytoin and folic acid: A two way interaction. Drug Intell Clin Pharm 1984;18(4):292-301.
5. Berg MJ, Rivey MP, Vern BA et al. Phenytoin and folic acid: individualized drug-drug interaction. Therapeutic Drug Monitoring 1983;5(4):395-9.
6. Boss GR, Ragsdale RA, Lettner A et al. Failure of folic acid (pteroylglutamic acid) to affect hyperuricemia. J Lab Clin Med 1980;96:783-9.
7. Botto LD, Oiney RS, Ericson JD. Vitamin supplements and the risk for congenital anomalies other than NTDs. Am J Med Genet C Semin Med Genet 2004;125:12-21.
8. Brunet L, Miranda J, Farré M et al. Gingival enlargement induced by drugs. Drug Saf 1996;15:219-31.
9. Campbell NR. How safe are folic acid supplements? Arch Intern Med 1996;156:1636-44.
10. Carl G Franklin, Hudson Farlyn Z, McGuire Byron S Jr. Phenytoin-Induced Depletion of Folate in Rats Originates in Liver and Involves a Mechanism That Does Not Discriminate Folate Form. J Nutr 1997;127(11):2231-8.
11. Chanarin I, Laidlow J, Lughridge LW et al. Megaloblastic anemia due to phenobarbitone: the convulsant action of therapeutic doses of folic acid. Br Med J 1960;1:1099-102.
12. Chien LT, Krumdieck CL, Scott CW Jr et al. Harmful effects of megadoses of vitamins: electroencephalogram abnormalities and seizures induced by intravenous folate in drug treated epileptics. Am J Clin Nutr 1975;28:51-8.
13. Ciancio SG. Gingival hyperplasia and diphenylhydantoin. J Perio 1972;(43):411.
14. Cseh I, Halasz P, Gati I. National center for epileptic pregnancies. Int J Gynecol Obstet 1991;29:suppl.44.
15. Czeizel AE. Peri-conceptional folic acid containing multivitamin supplementation. Eur J Obstet Gynaecol Reprod Biol 1998;78:151-61.
16. Czeizel AE, Bod M, Halasz P. Evaluation of anti-convulsant drugs during pregnancy in a population-based Hungarian study. Eur J Epidemiol 1992;8:122-7.
17. Dansky LV, Andermann E, Rosenblatt D et al. Anticonvulsants, folate levels and pregnancy outcome: a prospective study. Ann Neurol 1987;27:176-82.
18. Davis J, Watkins JC. Facilitatory and direct excitatory effects of folate and folinate on single neurons of cat cerebral cortex. Biochem Pharmacol 1973;22:1667-8.
19. Davis RE. Effects of folic acid [letter]. Lancet 2002;359:2038-9.
20. Gibberd FB, Nicholls A, Wright MG. The influence of folic acid on the frequency of epileptic attacks. Eur J Clin Pharmacol 1981;19:57-60.
21. Grant RH, Stores OP. Folic acid in folate deficient patients with epilepsy. Br Med J 1970;4:644-8.
22. Guidolin L, Vignoli A, Canger R. Worsening in seizure frequency and severity in relation to folic acid administration. Eur J Neurol 1998;5:301-3.
23. Hassessian A, Marcucci G, Guimarães Júnior J. Freqüência da hyperplasia gengival medicamentosa em 48 pacientes tratados com nifedipina. Revista Abo Nacional Rio de Janeiro 2003;11:28-32.
24. Hassell TM, Burtner A Paul, McNeal Donald et al. Hypertrophic Oral problems and genetic aspects of individuals with epilepsy. Periodontology 2000;6(6):68.
25. Hommes OR, Hollinger JL, Jansen MJT et al. Convulsant properties of folate compounds, some considerations and speculations. In:Botez MI, Reynolds EH, eds. Folic acid in Neurology, Psychiatry and Internal Medicine. New York, Raven Press, 1979:285-316.
26. Hommes OR, Obbens EAMT, Wijfeels CCB. Epileptogenic activity of sodium-folate and the blood-brain barrier in the rat. J Neurol Sci 1973;19:63-71.
27. Houlihan CM, Scott JM, Boyle PH et al. The effect of phenytoin on the absorption of synthetic folic acid polyglutamate. Gut 1972;(13):189-90.
28. Itemobong Ekaidem S, Monday Akpanabiatu I, Friday Uboh E et al. Effect of folic acid and vitamin B12 administration on phenytoin induced toxicity in rats. Indian Journal of Clinical Biochemistry 2007;22(2):36-40.
29. Kelly Deirdre, Weir Donald, Reed Berenice et al. Effect of Anticonvulsant Drugs on the Rate of Folate Catabolism in Mice. J Clin Invest 1979;(64):1089-96.
30. Kjær D, Horvath-Puhó E, Christensen J et al. Antiepileptic drug use, folic acid supplementation, and congenital abnormalities: a population-based case-control study. BJOG 2008;115:98-103.
31. Latham AN, Richens Millbank A, Rowe DJF. Liver enzyme induction by anti-convulsant drugs and its relationship to disturbed calcium and folic acid metabolism. The Journal of Clinical Pharmacology and New Drugs 1973;(13):337-42.
32. Lewis DP, Van Dyke DC, Willhite LA et al. Phenytoin-folic acid interaction. The Annals of Pharmacotherapy 1995;29(7):726-35.
33. Linnebank M, Moskau S, Semmler A et al. Antiepileptic drugs interact with folate and vitamin B12 serum levels. Ann Neurol 2011;69:352-9.
34. Majola MP, McFadyen ML, Connolly C et al. Factors influencing phenytoin-induced gingival enlargement. Journal of Clinical Periodontology 2000;27:506-12.
35. Malpas JS, Spray GH, Wiits LJ. Serum Folic-acid and Vitamin- B12 Levels in Anticonvulsant Therapy. Brit Med J 1966;(1):955-7.
36. Maxwell JD, Hunter John, Stewart DA et al. Folate Deficiency after Anticonvulsant Drugs: An Effect of Hepatic Enzyme Induction? Br Med J 1972;1(5795):297-9.
37. Miller AA, Goff D, Webster RA. Predisposition of laboratory animals to epileptogenic activity of folic acid. In:Botez MI, Reynolds EH, eds. Folic acid in Neurology, Psychiatry and Internal Medicine. New York, Raven Press, 1979:331-4.
38. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991;327:1832-5.
39. Myers MF, Li S, Correa-Vilasenor A et al. Folic acid supplementation and the risk of imperforatde anus in China. Am J Epidemiol 2001;154:1051-6.
40. Olney JW, Fuller TA, de Gubareff T et al. Intrastriatal folic acid mimics the distant but not focal brain damaging properties of kainic acid. Neurosci Letter 1981;25:185-91.
41. Ralston AJ, Snaith RP, Hinley JB. Effects of folic acid on fit frequency and behavior in epileptics on anticonvulsants. Lancet 1970;1:867-8.
42. Richens A, Waters AH. Acute effect of phenytoin on serum folate concentration. British Journal of Pharmacology 1971;41(2):414.
43. Reynolds EH, Gallagher BB, Mattson RH et al. Relationship between serum and cerebrospinal fluid folate. Nature 1972;240:155-7.
44. Reynolds EH. Neurological aspects of folate and vitamin B12 metabolism. In:Hoffbrand AV, ed. Clinics in Haematology, volume 5. London:Saunders,1976:661-96.
45. Reynolds EH. Effects of folic acid [letter]. Lancet 2002;359:2039-40.
46. Reynolds EH. Benefits and risks of folic acid to the nervous system. J Neurol Neurosurg Psychiatry 2002;72:767-71.
47. Reynolds EH, Preece J, Johnson AL. Folate metabolism in epileptic and psychiatric patients. J Neurol Neurosurg Psychiat 1971;(34):726-32.
48. Scheinfeld N. Phenytoin in cutaneous medicine: its uses, mechanisms and side effects". Dermatol Online J 2003;9(3):6.
49. Sener Ufuk, Zorlu Yasar, Karaguzel Oguz et al. Effects of common anti-epileptic drug monotherapy on serum levels of homocysteine, Vitamin B12, folic acid and Vitamin B6. Seizure 2006;15:79-85.
50. Smithells RW, Nevin NC, Seller MJ et al. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1983;1:1027-31.
51. Smithells RW, Sheppard S, Schorah CJ. Vitamin deficiencies and neural tube defects. Arch Dis Child 1976;51:944-50.
52. Spaans F. No effect of folic acid supplement on CSF folate and serum vitamin B12 in patients on anticonvulsants. Epilepsia 1970;11:403- 11.
53. Sridharan R. Epidemiology of epilepsy. Current Science 2002;82(6):664-70.
54. Sridharan R, Murthy BN. Prevalence and pattern of epilepsy in India. Epilepsia 1999;40:631-6.
55. Strauss RG, Bernstein R. Folic acid and dilantin antagonism in pregnancy. Obstet Gynecol 1975;44:345-8.
56. Wald NJ, Law MR, Morris JK et al. Quantifying the effect of folic acid. Lancet 2001;358:2069-73.
57. Wells DG, Casey HJ. Lactobacillus casei C.S.F. folate activity. Br Med J 1967;3(5569):834-6.
58. Yerbi MS. Teratogenic effects of antiepileptic drugs: what do we advise patients. Epilepsia 1997;38:957-8.